Abstract
Background
Multiple endocrine neoplasia type 1 (MEN1) is a rare syndrome that combines endocrine and non-endocrine tumors. Thymic neuroendocrine tumors are uncommon components that predict poor prognosis in patients with MEN1. We aimed to summarize the clinical characteristics of thymoma in MEN1 by reviewing the current reports from the literature.
Methods
A patient with multiple endocrine neoplasia type 1 (parathyroid hyperplasia, pituitary adenoma, and insulinoma) was found to have a 2 × 1.5 cm thymic mass during long-term follow-up. Thoracoscope surgery was performed, and a histopathology examination revealed WHO Type B3 thymoma. A pathogenic mutation of c.783 + 1G > A in the MEN1 gene was identified. We further searched PubMed and EMBASE for thymoma in association with MEN1.
Results
A comprehensive overview of the literature concerning characteristics of MEN1-related thymoma was summarized. Clinical characteristics and differences between thymoma and thymic carcinoid are highlighted.
Conclusions
Besides carcinoid, other tumors, including thymoma, need to be identified for thymic space-occupying lesions in MEN1 patients. The impact of thymoma on the long-term prognosis of MEN1 patients needs further investigation.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Abbreviations
- MEN1:
-
multiple endocrine neoplasia type 1
- CT:
-
computed tomography
- PA:
-
pituitary adenoma
- MG:
-
myasthenia gravis
- PHPT:
-
primary hyperparathyroidism
- EPT:
-
nteropancreatic endocrine tumors
- AT:
-
adrenocortical tumor
- surg:
-
surgery
- radio:
-
radiotherapy.
References
R.V. Thakker, P.J. Newey, G.V. Walls, J. Bilezikian, H. Dralle, P.R. Ebeling, S. Melmed, A. Sakurai, F. Tonelli, M.L. Brandi et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97(9), 2990–3011 (2012)
S.K. Agarwal, The future: genetics advances in MEN1 therapeutic approaches and management strategies. Endocr. Relat. Cancer 24(10), T119–T134 (2017)
S.G. Waguespack, Beyond the “3 Ps”: a critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1. Front. Endocrinol. 13, 1029041 (2022)
J.M. de Laat, C.R. Pieterman, M.F. van den Broek, J.W. Twisk, A.R. Hermus, O.M. Dekkers, W.W. de Herder, A.N. van der Horst-Schrivers, M.L. Drent, P.H. Bisschop et al. Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients. J. Clin. Endocrinol. Metab. 99(9), 3325–3333 (2014)
N. Singh Ospina, G.B. Thompson, F.R.C. Nichols, S.D. Cassivi, W.F. Young Jr, Thymic and bronchial carcinoid tumors in multiple endocrine neoplasia type 1: the Mayo Clinic experience from 1977 to 2013. Horm. Cancer 6(5–6), 247–253 (2015)
I. Christakis, W. Qiu, A.M. Silva Figueroa, S. Hyde, G.J. Cote, N.L. Busaidy, M. Williams, E. Grubbs, J.E. Lee, N.D. Perrier, Clinical features, treatments, and outcomes of patients with thymic carcinoids and multiple endocrine neoplasia type 1 syndrome at MD Anderson Cancer Center. Horm. Cancer 7(4), 279–287 (2016)
L. Ye, W. Wang, N.S. Ospina, L. Jiang, I. Christakis, J. Lu, Y. Zhou, W. Zhu, Y. Cao, S. Wang et al. Clinical features and prognosis of thymic neuroendocrine tumors associated with multiple endocrine neoplasia type 1: a single-center study, systematic review, and meta-analysis. Clin. Endocrinol. 87(6), 706–716 (2017)
F.J. Palmer, T.M. Sawyers, Hyperparathyroidism, chemodectoma, thymoma, and myasthenia gravis. Arch. Intern. Med. 138(9), 1402–1403 (1978)
L.J. Vroegindeweij-Claessens, C.C. Tijssen, G.J. Creemers, J.H. Lockefeer, J.L. Teepen, Myasthenia gravis and thymoma in multiple endocrine neoplasias (MEN-1) syndrome. J. Neurol. Neurosurg. Psychiatry 53(7), 624–625 (1990)
G. De Toma, M. Plocco, V. Nicolanti, S. Brozzetti, C. Letizia, A. Cavallaro, Type B1 thymoma in multiple endocrine neoplasia type 1 (MEN-1) syndrome. Tumori 87(4), 266–268 (2001)
Y. Kojima, H. Ito, S. Hasegawa, T. Sasaki, K. Inui, Resected invasive thymoma with multiple endocrine neoplasia type 1. Jpn J. Thorac. Cardiovasc. Surg. 54(4), 171–173 (2006)
B.S. Miller, R.Y. Rusinko, L. Fowler, Synchronous thymoma and thymic carcinoid in a woman with multiple endocrine neoplasia type 1: a case report and review. Endocr. Pr. 14(6), 713–716 (2008)
M.J. Hall, J. Innocent, C. Rybak, C. Veloski, W.J. Scott, H. Wu, J.A. Ridge, J.P. Hoffman, H. Borghaei, A. Turaka, M.B. Daly, Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion. Appl. Clin. Genet. 8, 69–73 (2015)
M. Tomita, N. Ichiki, T. Ayabe, H. Tanaka, H. Kataoka, K. Nakamura, Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1. J. Surg. Case Rep. 2017(4), rjx071 (2017)
Z. Fan, L. Wang, J. Wang, C. Gu, Thymoma (World Health Organization Type AB) in multiple endocrine neoplasia type 1: a case report. J. Surg. Case Rep. 2022(7), rjac290 (2022)
Expert Committee on Neuroendocrine Neoplasms CSoCO, [Chinese expert consensus on lung and thymus neuroendocrine neoplasms]. Zhonghua Zhong Liu Za Zhi 43(10), 989–1000 (2021)
J. Rosai, E. Higa, J. Davie, Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatoses. A previously unrecognized association. Cancer 29(4), 1075–1083 (1972)
A. Sakurai, S. Suzuki, S. Kosugi, T. Okamoto, S. Uchino, A. Miya, T. Imai, H. Kaji, I. Komoto, D. Miura et al. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin. Endocrinol. 76(4), 533–539 (2012)
G. Effraimidis, U. Knigge, M. Rossing, P. Oturai, A.K. Rasmussen, U. Feldt-Rasmussen, Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs). Semin. Cancer Biol. 79, 141–162 (2022)
A.G. Knudson Jr, Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68(4), 820–823 (1971)
C. Larsson, B. Skogseid, K. Oberg, Y. Nakamura, M. Nordenskjold, Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332(6159), 85–87 (1988)
R.V. Thakker, P. Bouloux, C. Wooding, K. Chotai, P.M. Broad, N.K. Spurr, G.M. Besser, J.L. O'Riordan, Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N. Engl. J. Med 321(4), 218–224 (1989)
A.A. Pannett, R.V. Thakker, Somatic mutations in MEN type 1 tumor, consistent with the Knudson “two-hit” hypothesis. J. Clin. Endocrinol. Metab. 86(9), 4371–4374 (2001)
D.C. Strollo, M.L. Rosado de Christenson, J.R. Jett, Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum. Chest 112(2), 511–522 (1997)
R. Dixit, N.S. Shah, M. Goyal, C.B. Patil, M. Panjabi, R.C. Gupta, N. Gupta, S.V. Harish, Diagnostic evaluation of mediastinal lesions: analysis of 144 cases. Lung India 34(4), 341–348 (2017)
A. Mandl, J.M. Welch, G. Kapoor, V.I. Parekh, D.S. Schrump, R.T. Ripley, M.F. Walter, J. Del Rivero, S. Jha, W.F. Simonds et al. Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus. Endocr. Relat. Cancer 28(11), L15–L19 (2021)
P. Goudet, A. Murat, C. Cardot-Bauters, P. Emy, E. Baudin, H. du Boullay Choplin, Y. Chapuis, J.L. Kraimps, J.L. Sadoul, A. Tabarin et al. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines). World J. Surg. 33(6), 1197–1207 (2009)
P. Ferolla, A. Falchetti, P. Filosso, P. Tomassetti, G. Tamburrano, N. Avenia, G. Daddi, F. Puma, R. Ribacchi, F. Santeusanio et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J. Clin. Endocrinol. Metab. 90(5), 2603–2609 (2005)
N. Singh Ospina, S. Maraka, V. Montori, G.B. Thompson, W.F. Young Jr, When and how should patients with multiple endocrine neoplasia type 1 be screened for thymic and bronchial carcinoid tumors? Clin. Endocrinol. 84(1), 13–16 (2016)
A. Lagarde, G. Mougel, L. Coppin, M. Haissaguerre, L. Le Collen, A. Mohamed, M. Klein, M.F. Odou, A. Tabarin, H. Brixi, T. Cuny, B. Delemer, A. Barlier, P. Romanet, Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms. Endocr. Connect 11(11), e220093 (2022)
Acknowledgements
Our patients acknowledge that they cannot be identified via the paper and have been fully anonymized.
Author information
Authors and Affiliations
Contributions
Y.G. and W.Z. prepared the manuscript; Y.G., L.W., R.L., and J.M. collected clinical data collection; Y.G. and R.L. searched the database and identified the included studies; H.Y. and W.Z. revised and oversaw the work. All authors participated in the discussions about the manuscript and approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Consent to participate
Written informed consent was obtained from the individual to publish any potentially identifiable images or data in this article.
Consent for publication
The authors affirm that all individual participants provided informed consent for the data publication. Additional informed consent was obtained from all individual participants for whom identifying information was included in this article.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gao, Y., Li, R., Wu, L. et al. Thymoma in multiple endocrine neoplasia type 1: a case report and systematic review. Endocrine 82, 442–449 (2023). https://doi.org/10.1007/s12020-023-03440-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03440-5